Serine-Selective Bioconjugation. by Vantourout, Julien C et al.
 
Serine-Selective Bioconjugation 
Julien C. Vantourout1, Srinivasa Rao Adusumalli2, Kyle W. Knouse1, Dillon Flood1, Antonio Ramirez4, 
Natalia M. Padial1, Alena Istrate2, Katarzyna Maziarz1, Justine N. deGruyter1, Rohan R. Merchant1, Jen-
nifer X. Qiao4, Michael A. Schmidt4, Michael J. Deery5, Martin D. Eastgate*4, Philip E. Dawson*1, Gon-
çalo J. L. Bernardes*2,3 and Phil S. Baran*1 
1Department of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla, CA 92037, United States. 
2Department of Chemistry, University of Cambridge, Lensfield Road, CB2 1EW Cambridge, United Kingdom. 
3Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028 
Lisboa, Portugal. 
4Chemical Process Development, Bristol-Myers Squibb, One Squibb Drive, New Brunswick, NJ 08903, United 
States. 
5Cambridge Centre for Proteomics, Milner Therapeutics Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, 
Puddicombe Way, CB2 0AW Cambridge, United Kingdom. 
ABSTRACT: The first general method for the rapid, chemoselective, and modular functionalization of serine residues in native 
polypeptides is reported using a reagent platform based on P(V) oxidation state. This redox-economic approach can be used to append 
nearly any kind of cargo onto serine, generating a stable, benign, and hydrophilic phosphorothioate linkage. The method tolerates all 
other known nucleophilic functional groups of naturally occurring proteinogenic amino acids. A variety of applications can be envis-
aged by this expansion of the toolbox of site-selective bioconjugation methods.
  It is no surprise that of the twenty naturally-occurring amino 
acid residues bearing reactive groups, serine is rarely chosen as 
a handle for selective derivatization (Figure 1A).1-4 This lack of 
serine functionalization clearly stems not from a lack of desire, 
but rather the unmet challenge of differentiating the nucleo-
philicity of serine residues from other nucleophilic sidechains 
and water (chemoselectivity) and single residue among its mul-
tiple copies (site-selectivity).1-7 A process that could achieve 
this differentiation would be inherently valuable, as it would 
add a new dimension to the toolbox of options available for 
chemoselective modification of peptides and the site-selective 
labeling of proteins. Whereas nature has pointed to a possible 
solution to this problem using enzymatic machinery and phos-
phorus(V) reactivity,8-16 there is currently no general method 
(chemoenzymatic or otherwise) to site-selectively attach a pre-
cise cargo to a serine residue in a native biomolecule.1-3,17 Ki-
nases are typically responsible for the phosphorylation of vari-
ous amino acid residues such as serine (Figure 1B).8-16 This pro-
cess suggests that P(V)-based electrophiles could have an innate 
preference for alcohol-based nucleophiles.18 In parallel with 
this biological precedent, chemical inspiration for P(V)-based 
bioconjugation stems from the new class of phosphorous rea-
gents (Y and P) which react with both oxygen- and carbon-
based nucleophiles in a rapid and predictable way.19,20 In this 
Communication, Y-loaded reagents (Y-modules) are shown to 
exhibit strikingly selective reactivity towards serine. This 
method enables both selective post-translational labeling and 
bioconjugation of serine residues. 
 
FIGURE 1. (A) Serine: Unanswered Challenge for Selective 
Amino Acid Functionalization. (B) PSI Reagents Mimic Natural 
P(V)-based Phosphorylation of Serine. 
  In 2018, a set of reagents based upon a limonene-scaffold 
fused to an oxathiophospholane heterocycle were introduced 
for the purpose of simplifying stereocontrolled  access to phos-
phorothioate linkages (Phosphorous-Sulfur Incorporation, ab-
breviated PSI or Y).19 This redox-economic approach avoided 
the extraneous steps associated  
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FIGURE 2. (A) Competitive Experiments Between Amino Acids. (B) Competitive Experiments Using Small Tetrapeptides (10 mM). a 
Using EtSH (5 equiv).
with a P(III)-based manifold, yet retained the high reactivity as-
sociated with phosphoramidites and related systems.19 Shortly 
thereafter, related limonene-based reagents were introduced to 
access both phosphines and methylphosphonates through stere-
ocontrolled P–C bond formation (Phosphorous Incorporation, 
abbreviated PI or P).20 
  During the studies using PSI reagent, it was sporadically ob-
served that oxygen-based nucleophiles would react in prefer-
ence to other heteroatoms such as sulfur and nitrogen.19,20 After 
optimization of the coupling step (see supporting information, 
Figure S23), the generality of these observations was explored 
systematically in the context of amino-acid functionalization as 
depicted in Figure 2A. Thus, competitive coupling experiments 
between amino acids revealed a striking selectivity for serine 
functionalization using Y-module P(V)-1 in the presence of 
cysteine, lysine, tyrosine and selenocysteine, even at high con-
centration (0.1 M). These preliminary studies established the vi-
ability of such an approach, and represent selectivities on par 
with traditional protein labeling methods (e.g. NHS esters for 
lysine, iodoacetamide for cysteine, and 
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FIGURE 3. (A) Peptide Scope. (B) Functionalization of Cyclic Peptide. 
MTAD for tyrosine/tryptophan).1-4 Interestingly, reagent P(V)-
1 under similar conditions displayed a respectable selectivity of 
7:1 favoring serine over threonine. Transitioning to more real-
istic models for chemoselective labeling, competitive coupling 
experiments were then pursued using small peptides with Y-
modules P(V)-1, P(V)-2a, and P(V)-3 (Figure 2B). Good-to-
excellent conversions were observed within 15 minutes, and un-
less otherwise noted, only one product was formed with no epi-
merization. Exquisite selectivity was obtained for serine at both 
50 mM and 100 mM reagent concentration (10 mM peptide 
concentration) when competing with cysteine, lysine, histidine, 
glutamine, methionine, tryptophan, and tyrosine. When em-
ploying cysteine containing peptides, excess EtSH was added 
to avoid the formation of adducts between cysteine and the 
thiirane by-product of the Y-module. In addition, a reductive 
quench (DTT) is used to reduce any S–S bond formed during 
the reaction.21,22 When competing with threonine, a useful level 
of selectivity (determined by H-coupled 31P NMR) was ob-
served at 50 mM of reagents P(V)-1 (8:1), P(V)-2a (6:1), or 
reagent P(V)-3 (7:1) delivering compounds 15, 16 and 17 in 
95%, 72% and 94%, respectively.1-4 
  More realistic applications of this method were then explored 
in the context of longer peptides containing a variety of nucle-
ophilic amino acids (Figure 3A). Excellent selectivity for serine 
and satisfactory conversions were always observed using a va-
riety of Y-modules (Figure 3A). As an example, peptides SI-14 
was selectively labelled at the serine position to afford peptide 
31, 32, and 33 in 23%, 36% and 17% conversions using rea-
gents P(V)-1, P(V)-2b, and P(V)-3, respectively. In addition to 
these linear examples, the functionalization of cyclic peptides 
was explored due to their importance and relevance in the con-
text of medicinal chemistry (Figure 3B).23-25 The developed 
conditions were first applied to the diversification of a cyclic 
peptide containing several nucleophilic functionalities, afford-
ing 61% yield of the desired product 34 within 10 minutes. An 
oxytocin-derivative, bearing a sensitive disulfide bridge and a 
tyrosine, successfully underwent coupling in 42% yield, with 
complete selectivity for the serine residue.26-28 Finally, vanco-
mycin was selected as a key example with an impressive func-
tional group array: one carboxylic acid, one primary amine, one 
primary amide, three phenolic alcohols, five secondary alco-
hols, and a single primary alcohol.29-33 Nevertheless, both rea-
gents P(V)-1 and P(V)-3 demonstrated remarkable selectivity 
for the primary alcohol site affording compounds  
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FIGURE 4. Functionalization of Proteins (A) Functionalization of 
Ubiquitin. (B) Functionalization of 434 Repressor. 
36 and 37 in 19% and 21% yields, respectively. The labeled po-
sition was confirmed by H-coupled 31P NMR; assignment was 
simple as the molecule bears only one primary alcohol. 
Next, we challenged this chemical method for the installation 
of various y-loaded reagents on proteins. The protein ubiquitin 
was primarily chosen for its relevance in proteasome target-
ing.34-36 When ubiquitin 38 was vortexed with P(V)-2b reagent 
and DBU, it resulted in mono-labeled ubiquitin 39 in 37% con-
version (Figure 4A). Labeled ubiquitin 39 was digested with 
trypsin and analyzed by LC-MS/MS (see SI for details). The 
resulting MS/MS data were searched using the Mascot search 
algorithm using a variable modification of 176 Da and a data-
base containing the ubiquitin sequence. MS/MS of P(V) tagged 
peptide (ESTLHLVLR, E64-R72, m/z 622.31 [M+2H]2+) con-
firmed the site-selective labeling of Ser residue (S65; kinetic 
labeling). Subsequently, other y-modules were screened for the 
labeling of ubiquitin. P(V)-1, P(V)-3, and P(V)-4 reagents af-
forded the mono-labeling of ubiquitin in 32% (40), 40% (41), 
and 20% (42) conversions respectively. In addition, the method 
was efficiently translated to the labeling of the DNA binding 
protein 434 repressor37-39 43 using P(V)-2b; reaction of these 
components delivered 44 in 35% conversion (Figure 4B). Fur-
ther advances in the design of y-reagents that are more reactive, 
yet more stable in aqueous conditions, and cysteine compatible 
will facilitate further use of this new approach toward the 
chemo- and regioselective modification of serine residues on 
proteins. 
  DFT studies were undertaken to rationalize the selectivity ob-
served for serine in the coupling step (Figure 5).40 These studies 
support a stepwise AN+DN phosphorylation mechanism (Figure 
5A) with limiting barriers for the formation (TS1) or collapse 
(TS2) of a trigonal bipyramidal pentacoordinated (TBP, INT1) 
intermediate (Figure 5B). The remaining steps of the reaction 
coordinate involve a ring flip of the limonene skeleton (TS3) 
followed by SN2 displacement of the phosphorylated amino acid 
and simultaneous release of the cyclohexene sulfide (TS4) with 
an exothermic balance (DG ≈ -37 kcal/mol).41 Transition struc-
tures TS3 represent the highest barrier within the sequence of 
conformational distorsions42 required to transform chair INT2 
into chair INT3 (See SI for details).43 The transition structures 
leading to the TBP, TS1, display the backside attack of the nu-
cleophile to the P-O ring bond in a late, intermediate-like ar-
rangement. TS1 shows a large extent of RX–P (where X = O, 
or N) bond formation and concomitant proton transfer to the ni-
trogen atom of DBU acting as a general base. Amino acids with 
alcohol and amine side chains display a rate-limiting formation 
of the trigonal bipyramidal intermediate with barriers that in-
crease in the order Ser < Thr << Tyr << Lys (TS1, Figure 5B). 
A DDG‡ of 0.6 kcal/mol between TS1-Ser and TS1-Thr is in 
qualitative agreement with the lower but competitive reactivity 
of threonine, whereas a DDG‡ of 4.9 kcal/mol between TS1-Ser 
and TS1-Tyr is consistent with the limited reactivity of tyrosine. 
Similarly, TS1-Ser is favored relative to TS1-Lys by ≈ 9 
kcal/mol in agreement with the lower acidity of the primary 
amine and greater steric congestion during the partial deproto-
nation by DBU. A search for the transition structures corre-
sponding to the collapse of the TBP intermediates led to struc-
tures TS2, which depict the dissociation of the ring S–P bond 
accompanied by pseudorotation44 and reduction of the O–P–O 
angle as the tetrahedral phosphorylated P(V) product forms 
(Figure 5A and SI for details). The formation of a strong O–P 
bond and the axial arrangement of the methoxy group facilitate 
the dissociation of the weaker S–P bond (See SI for details).45 
For amino acids with alcohol side chains, transition structures 
TS2 leading to the collapse of the TBP intermediates are ≈ 8 
kcal/mol more stable than the transition structures TS1 forming 
the TBP intermediates. In contrast with the reaction coordinate 
for the alcohol, the collapse of the TBP-Cys intermediate is dis-
favored relative to its formation (cf. TS1-Cys and TS2-Cys, 
Figure 5B). The existence of a low barrier for decomposition of 
the TBP intermediate back to reactants has been used to explain 
the slow thiolysis of phosphate triesters.46 In agreement with 
experiment, the limiting barrier for the phosphorylation of cys-
teine (TS2-Cys, DG‡ = +22.2 kcal/mol) is estimated to be 2.7 
kcal/mol higher than the limiting barrier for the phosphorylation 
of serine (TS1-Ser, DG‡ = +19.5 kcal/mol). A comparison of 
TS2-Cys and TS2-Ser geometries shows the reluctance of cys-
teine to pseudorotate (S–P–Oring 147.0° in TS2-Cys versus 
111.2° in TS2-Ser), become equatorial, and stabilize ring P–S 
dissociation via the axial-axial arrangement of the OMe group 
and the ring P–S bond (See SI). The higher pseudorotation bar-
rier of cysteine relative to serine is consistent with the prefer-
ence of good leaving groups (e.g. cysteine) to occupy an axial 
position.47 It worth noting that the selectivity for serine versus 
cysteine and tyrosine may simply be associated with a higher 
degree of reversibility. Taken all together, 
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FIGURE 5. (A) General Stepwise Mechanism of the Coupling Step. (B) DFT Calculations to Rationalize the Serine Selectivity.
these results rationalize the serine selectivity observed for the 
coupling step. 
  Expanding on our previous work on the chemistry of the y-
reagent system, a chemoselective, rapid, and robust method for 
the direct functionalization of serine residues in the context of 
both peptides and proteins has been developed. The presented 
methodology displays excellent chemoselectivity for serine res-
idues under the optimized solvent conditions and will enable 
practitioners in this field to append virtually any kind of cargo 
desired in an orthogonal fashion. Applications of these findings 
to bioconjugation, chemical biology, as well as the pursuit of 
novel materials can all be envisaged.48 Development of new 
PSI-reagents that are compatible to aqueous conditions and cys-
teine residues will also facilitate further use of this new ap-
proach toward the chemo- and regioselective modification of 
serine residues on proteins. 
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